Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous v3.6.0 tag to reflect a newer version.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page adds a recruitment-status notice and new user guidance sections, along with a UI revision note indicating the version change.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4. This indicates a version update of the page content rather than changes to the study details.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page's revision tag has been updated to v3.5.4, replacing the previous v3.5.3. This reflects a small, non-content-related update to the page version.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page shows a new Revision: v3.5.3, replacing the previous Revision: v3.5.2, indicating a content update.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.